| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/21/2000 | US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 03/21/2000 | US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 03/21/2000 | US6040309 Benzothiophene derivatives useful in therapy |
| 03/21/2000 | US6040292 Methods for treating diabetes |
| 03/21/2000 | US6040289 Active drug treating obesity |
| 03/21/2000 | US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides |
| 03/21/2000 | US6040147 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 03/21/2000 | US6040133 D-enzyme compositions and methods of their use |
| 03/21/2000 | CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors |
| 03/21/2000 | CA2132745C Novel cardioprotective agents |
| 03/21/2000 | CA2027773C Treatment of shock by cyclodextrins and their derivatives |
| 03/21/2000 | CA2027743C Diuresis by cyclodextrins and their derivatives |
| 03/17/2000 | CA2282112A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| 03/16/2000 | WO2000014235A1 Kunitz domain polypeptide zkun6 |
| 03/16/2000 | WO2000014095A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/16/2000 | WO2000014088A1 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction |
| 03/16/2000 | WO2000014086A1 Chemokine receptor antagonists and methods of use therefor |
| 03/16/2000 | WO2000014084A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents |
| 03/16/2000 | WO2000014067A1 Piperidine derivatives |
| 03/16/2000 | WO2000014066A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 03/16/2000 | WO2000014054A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 03/16/2000 | WO2000013712A2 Methods and compositions for the prevention or treatment of cancer |
| 03/16/2000 | WO2000013710A2 Hydrogel compositions for the controlled release administration of growth factors |
| 03/16/2000 | WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 03/16/2000 | WO2000013703A2 Methods of treating hypertension and compositions for use therein |
| 03/16/2000 | WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 03/16/2000 | WO2000013701A2 Angiogenically effective unit dose of fgf-2 and method of use |
| 03/16/2000 | WO2000013698A1 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system |
| 03/16/2000 | WO2000013696A1 Composition for improving mental capabilities in mammals |
| 03/16/2000 | WO2000013691A2 3-deazaadenosine prevents atherosclerosis and graft vasculopathy |
| 03/16/2000 | WO2000013687A2 Sustained release ranolazine formulations |
| 03/16/2000 | WO2000013686A2 Sustained release ranolazine formulations |
| 03/16/2000 | WO2000013668A1 Microparticles |
| 03/16/2000 | WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/16/2000 | WO1999067363A9 Ependymal neural stem cells and method for their isolation |
| 03/16/2000 | WO1999066912A3 Method of treating pulmonary hypertension |
| 03/16/2000 | WO1999061471A3 Human transmembrane proteins |
| 03/16/2000 | WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders |
| 03/16/2000 | DE19845434C1 Tissue binding peptides and related nucleotide sequences useful for tissue specific gene transfer |
| 03/16/2000 | DE19841930A1 Stabile, pulverförmige Lycopin-Formulierungen, enthaltend Lycopin mit einem Kristallinitätsgrad von größer 20% Sturdy, powder-like lycopene formulations comprising lycopene having a degree of crystallinity of greater than 20% |
| 03/16/2000 | CA2343168A1 Piperidine derivatives |
| 03/16/2000 | CA2343027A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/16/2000 | CA2342921A1 Drug screening and diagnosis based on paracrine tubular renin-angiotensin system |
| 03/16/2000 | CA2342898A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 03/16/2000 | CA2342882A1 Chemokine receptor antagonists and methods of use therefor |
| 03/16/2000 | CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
| 03/16/2000 | CA2341752A1 Methods and compositions for the prevention or treatment of cancer |
| 03/16/2000 | CA2341353A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents |
| 03/16/2000 | CA2341325A1 Method of stimulating prosaposin receptor activity |
| 03/16/2000 | CA2306165A1 Composition for improving mental capabilities in mammals |
| 03/15/2000 | EP0985149A1 Methods for evaluating tissue morphogenesis and activity |
| 03/15/2000 | EP0985038A1 Sodium channel receptor |
| 03/15/2000 | EP0985028A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 03/15/2000 | EP0984965A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 03/15/2000 | EP0984963A1 Novel compounds |
| 03/15/2000 | EP0984959A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 03/15/2000 | EP0984955A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNF$g(a) LEVELS |
| 03/15/2000 | EP0984952A1 A new salt |
| 03/15/2000 | EP0984930A1 2-indolinone derivatives as modulators of protein kinase activity |
| 03/15/2000 | EP0984928A1 Aromatic and heterocyclic nitrato derivatives |
| 03/15/2000 | EP0984787A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas |
| 03/15/2000 | EP0984779A1 Somatostatin agonists |
| 03/15/2000 | EP0984778A1 Neuropeptide-y ligands |
| 03/15/2000 | EP0984692A1 Novel angiogenesis inhibitors |
| 03/15/2000 | EP0783504B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS |
| 03/15/2000 | EP0664802B1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 03/15/2000 | EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 03/15/2000 | EP0656008B1 Thrombin receptor antagonists |
| 03/15/2000 | EP0619805B1 5-(hetero- or carbocyclylamino)-indole derivatives, their preparation and their use as 5-ht1 agonists |
| 03/15/2000 | EP0589937B1 Use of 4-(4-chlorophenyl-sulphonylcarbamoyl) benzoyl-l-valyl-l-proline 1(rs)-(1-trifluoroacetyl-2-methylpropyl) amide for the preparation of a medicament for the treatment of vascular diseases |
| 03/15/2000 | EP0567566B1 Methods for treating tumor necrosis factor mediated diseases |
| 03/15/2000 | EP0533703B1 Use of steroids for the inhibition of angiogenesis |
| 03/15/2000 | CN1247568A Fibroblast growth factor homologs |
| 03/15/2000 | CN1247539A Process for preparing eprosartan |
| 03/15/2000 | CN1247538A Process for preparing eprosartan |
| 03/15/2000 | CN1247537A Sulfonamide compounds having 5-HT receptor activity |
| 03/15/2000 | CN1247533A Heterocyclic carboxylic acid derivatives, prodn. and use thereof as endothelin receptor antagonists |
| 03/15/2000 | CN1247191A Imidazolium compound as synthetic material of imidazole lipoxidase inhibitor |
| 03/15/2000 | CN1247075A Chinese patent medicine for treating piles |
| 03/15/2000 | CN1050283C Gel-type cosmetic composite |
| 03/14/2000 | US6037488 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 03/14/2000 | US6037363 Respiratory system disorders, cystic fibrosis |
| 03/14/2000 | US6037356 Anticoagulants; antiinflammatory and antiarthritic agents |
| 03/14/2000 | US6037334 Inhibitors of factor xa that can be used to prevent diseases such asthrombosis, apoplexy, coronary infarction, inflammations, and arteriosclerosis |
| 03/14/2000 | US6037325 Certain substituted oxadiazole, thiadiazole and triazole peptoids used effectively to prevent, alleviate or otherwise treat disease states characterized by the degradation of connective tissue such as respiratory system disorders and |
| 03/14/2000 | US6037323 Peptides and peptide analogues that mimic the structural and pharmacological properties of human apoa-i; treating disorders associated with dyslipoproteinemia, including hypercholesterolemia, cardiovascular disease, atherosclerosis, |
| 03/14/2000 | US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor |
| 03/14/2000 | US6036126 Apparatus for separating particles of cohesive material according to size and process |
| 03/14/2000 | CA2195213C Use of droloxifene for the treatment of cardiovascular diseases |
| 03/14/2000 | CA2117643C Indole derivatives |
| 03/14/2000 | CA2009542C Cyclic guanidines as calcium antagonists |
| 03/14/2000 | CA2008263C Pyrazolopyridine compound and processes for preparation thereof |
| 03/09/2000 | WO2000012741A2 Inducible expression system |
| 03/09/2000 | WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 03/09/2000 | WO2000012720A2 Elongase genes and uses thereof |
| 03/09/2000 | WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 03/09/2000 | WO2000012682A1 Primate embryonic stem cells with compatible histocompatibility genes |
| 03/09/2000 | WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
| 03/09/2000 | WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof |
| 03/09/2000 | WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3 |